While the drugs certainly contribute to weight loss and health gains, they also cause a decline in muscle that some doctors ...

Scientists are calling for clinical trials after discovering a drug already prescribed for a virus affecting millions may also help prevent Alzheimer's too.

Researchers found the PHGDH gene directly causes Alzheimer’s and discovered a drug-like molecule, NCT-503, that may help ...

A new study has found that a common class of medications could dramatically decrease the risk of developing the neurodegenerative disorder.

Lecanemab and donanemab (Kisunla), another anti-amyloid treatment, won approval based on evidence that they slowed cognitive ...

In a recent study, researchers found adverse events were rare and manageable among clinic patients with very mild or mild Alzheimer's disease who received lecanemab infusions.

The Food and Drug Administration's approval in 2023 of lecanemab - a novel Alzheimer's therapy shown in clinical trials to modestly slow disease progression - was met with enthusiasm by many in the ...